Blood Transfusion Diagnostics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	190 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224257

Best Price Guarantee
Price	from $4,850
Length	190 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224257

Blood Transfusion Diagnostics Market

Growth Factors of Blood Transfusion Diagnostics Market

The blood transfusion diagnostics market size was valued at USD 4.98 billion in 2023, and the market is now projected to grow from USD 5.33 billion in 2024 to USD 9.64 billion by 2032, exhibiting a CAGR of 7.7% during the forecast period of 2023-2032.

Government has put restrictions on social gatherings, events and moving out from home which make the people homesick. Numerous companies are encountering hurdles due to covid pandemic as the outbreak situation has curtailed production and supply chain which has hindered the pneumonia testing market switched to treating covid patients as priority over the other procedures which led the blood transfusion diagnostics market growth.

Increasing blood and blood component demand to promote blood transfusion diagnostics market growth during the upcoming years. demand. Chronic kidney disease (CKD), hemophilia, cancer, thrombocytopenia, and other blood-related illnesses are becoming more common, which has increased the demand for whole blood transfusions and blood products. Blood transfusions are frequently necessary for patients with these diagnoses to manage their diseases on a regular basis. In addition, the need for blood transfusions is being fueled by an increase in the number of births, surgeries, and trauma cases conducted worldwide.

Transition to automated molecular platforms to quicken market expansion. The transition from manual tests and instruments to semi-automated and completely automated equipment is accelerating because to the launch of sophisticated molecular platforms by major players in the industry. These automated platforms can accurately reduce human error throughout the transfusion process and have been significant in the quick diagnosis of Transfusion-Transmissible Infections (TTIs) in blood samples.

Comprehensive Analysis of Blood Transfusion Diagnostics Market

The blood transfusion diagnostics market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by product, by application and by end users. The product segmentation includes, Instruments, and Reagents & Kits, By Application segmentation includes Blood Screening, and Blood Group Typing. However, the end users segmentation includes Hospital-based Laboratories, and Independent Laboratories & Blood Banks.

The North America region lead the blood transfusion diagnostics market by benefitting a market size of USD 1.99 billion in 2023 due to increased public awareness of blood donations, a more widely adopted blood transfusion procedure, and a well-established healthcare infrastructure.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QuidelOrtho Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QUOTIENT (Switzerland), Merck KGaA (Germany), Abbott (U.S.) these market players provide a level-playing competitive landscape.

In November 2023, In order to make pre-transfusion compatibility testing easier for patients with multiple myeloma, Grifols introduced Grifols sCD38 solution.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 7.7% from 2024-2032

Unit Value (USD Billion)

Segmentation By Product

Instruments
Kits & Reagents

By Application

Blood Screening
Blood Group Typing

By End-user

Hospital-based Laboratories
Independent Laboratories & Blood Banks

By Geography

North America (By Product, By Application, By End-user, and By Country)
U.S. (By Application)
Canada (By Application)
Europe (By Product, By Application, By End-user, and By Country/ Sub-region)
U.K. (By Application)
Germany (By Application)
France (By Application)
Italy (By Application)
Spain (By Application)
Scandinavia (By Application)
Rest of Europe (By Application)
Asia Pacific (By Product, By Application, By End-user, and By Country/ Sub-region)
China (By Application)
Japan (By Application)
India (By Application)
Australia (By Application)
Southeast Asia (By Application)
Rest of Asia Pacific (By Application)
Latin America (By Product, By Application, By End-user, and By Country/ Sub-region)
Brazil (By Application)
Mexico (By Application)
Rest of Latin America (By Application)
Middle East & Africa (By Product, By Application, By End-user, and By Country/ Sub-region)
GCC (By Application)
South Africa (By Application)
Rest of the Middle East & Africa (By Application)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Blood Donations Statistics, By Key Countries, 2023; 4.2. Impact of COVID-19 on the Market; 4.3. Prevalence of Key Bleeding Disorders, Key Regions/ Country, 2023; 4.4. Blood Group Distribution Among Blood Donors in China; 4.5. Distribution of Blood Group Type Among Indian & the U.S. Population; 4.6. Blood Transfusion Statistics, 2023; 4.7. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
5. Global Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Product; 5.1.1. Instruments; 5.1.2. Reagents & Kits; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Blood Screening; 5.2.2. Blood Group Typing; 5.3. Market Analysis, Insights and Forecast – By End-user; 5.3.1. Hospital-based Laboratories; 5.3.2. Independent Laboratories & Blood Banks; 5.4. Market Analysis, Insights and Forecast – By Region; 5.4.1. North America; 5.4.2. Europe; 5.4.3. Asia Pacific; 5.4.4. Latin America; 5.4.5. Middle East & Africa
6. North America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Product; 6.1.1. Instruments; 6.1.2. Reagents & Kits; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Blood Screening; 6.2.2. Blood Group Typing; 6.3. Market Analysis, Insights and Forecast – By End-user; 6.3.1. Hospital-based Laboratories; 6.3.2. Independent Laboratories & Blood Banks; 6.4. Market Analysis, Insights and Forecast – By Country; 6.4.1. U.S.; 6.4.1.1. By Application; 6.4.2. Canada; 6.4.2.1. By Application
7. Europe Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Product; 7.1.1. Instruments; 7.1.2. Reagents & Kits; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Blood Screening; 7.2.2. Blood Group Typing; 7.3. Market Analysis, Insights and Forecast – By End-user; 7.3.1. Hospital-based Laboratories; 7.3.2. Independent Laboratories & Blood Banks; 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 7.4.1. U.K.; 7.4.1.1. By Application; 7.4.2. Germany; 7.4.2.1. By Application; 7.4.3. France; 7.4.3.1. By Application; 7.4.4. Spain; 7.4.4.1. By Application; 7.4.5. Italy; 7.4.5.1. By Application; 7.4.6. Scandinavia; 7.4.6.1. By Application; 7.4.7. Rest of Europe; 7.4.7.1. By Application
8. Asia Pacific Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Product; 8.1.1. Instruments; 8.1.2. Reagents & Kits; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Blood Screening; 8.2.2. Blood Group Typing; 8.3. Market Analysis, Insights and Forecast – By End-user; 8.3.1. Hospital-based Laboratories; 8.3.2. Independent Laboratories & Blood Banks; 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 8.4.1. Japan; 8.4.1.1. By Application; 8.4.2. China; 8.4.2.1. By Application; 8.4.3. India; 8.4.3.1. By Application; 8.4.4. Australia; 8.4.4.1. By Application; 8.4.5. Southeast Asia; 8.4.5.1. By Application; 8.4.6. Rest of Asia Pacific; 8.4.6.1. By Application
9. Latin America Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Product; 9.1.1. Instruments; 9.1.2. Reagents & Kits; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Blood Screening; 9.2.2. Blood Group Typing; 9.3. Market Analysis, Insights and Forecast – By End-user; 9.3.1. Hospital-based Laboratories; 9.3.2. Independent Laboratories & Blood Banks; 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 9.4.1. Brazil; 9.4.1.1. By Application; 9.4.2. Mexico; 9.4.2.1. By Application; 9.4.3. Rest of Latin America; 9.4.3.1. By Application
10. Middle East & Africa Blood Transfusion Diagnostics Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Product; 10.1.1. Instruments; 10.1.2. Reagents & Kits; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Blood Screening; 10.2.2. Blood Group Typing; 10.3. Market Analysis, Insights and Forecast – By End-user; 10.3.1. Hospital-based Laboratories; 10.3.2. Independent Laboratories & Blood Banks; 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region; 10.4.1. GCC Countries; 10.4.1.1. By Application; 10.4.2. South Africa; 10.4.2.1. By Application; 10.4.3. Rest of Middle East & Africa; 10.4.3.1. By Application
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Abbott; 11.2.1.1. Overview; 11.2.1.2. Products & Services; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based on Availability); 11.2.2. F. Hoffmann-La Roche AG; 11.2.2.1. Overview; 11.2.2.2. Products & Services; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based on Availability); 11.2.3. Grifols, S.A.; 11.2.3.1. Overview; 11.2.3.2. Products & Services; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based on Availability); 11.2.4. Immucor, Inc.; 11.2.4.1. Overview; 11.2.4.2. Products & Services; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based on Availability); 11.2.5. Bio-Rad Laboratories, Inc.; 11.2.5.1. Overview; 11.2.5.2. Products & Services; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based on Availability); 11.2.6. Ortho Clinical Diagnostics; 11.2.6.1. Overview; 11.2.6.2. Products & Services; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based on Availability); 11.2.7. QUOTIENT; 11.2.7.1. Overview; 11.2.7.2. Products & Services; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based on Availability); 11.2.8. Merck KGaA; 11.2.8.1. Overview; 11.2.8.2. Products & Services; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based on Availability); 12.